0001209191-23-058860.txt : 20231215
0001209191-23-058860.hdr.sgml : 20231215
20231215180559
ACCESSION NUMBER: 0001209191-23-058860
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231213
FILED AS OF DATE: 20231215
DATE AS OF CHANGE: 20231215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Mark Andrew
CENTRAL INDEX KEY: 0001808356
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-24006
FILM NUMBER: 231491697
MAIL ADDRESS:
STREET 1: 1613 RAY DRIVE
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS
CENTRAL INDEX KEY: 0000906709
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943134940
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 4154825300
MAIL ADDRESS:
STREET 1: 455 MISSION BAY BOULEVARD SOUTH
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC
DATE OF NAME CHANGE: 19980723
FORMER COMPANY:
FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS
DATE OF NAME CHANGE: 19940303
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-12-13
0
0000906709
NEKTAR THERAPEUTICS
NKTR
0001808356
Wilson Mark Andrew
C/O NEKTAR THERAPEUTICS
455 MISSION BAY BLVD SOUTH, SUITE 100
SAN FRANCISCO
CA
94158
0
1
0
0
Chief Legal Officer
0
Stock Option
0.50
2023-12-13
4
A
0
325000
0.00
A
2031-12-12
Common Stock
325000
325000
D
This stock option vests over three years from the date of grant, (December 13, 2023) in equal monthly installments based on continued service.
Mark A. Wilson, Attorney-in-Fact
2023-12-15